The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression
Clinical trial NCT03386448 · COMPLETED
Trial details
- NCT number
- NCT03386448
- Sponsor
- The Taub Group
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2018-11-20
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.